Factor V Arg2074Cys: A Novel Missense Mutation in the C2 Domain of Factor V

Anna Bossone; Francesca D’Angelo; Rosa Santacroce; Domenico De Lucia; Maurizio Margaglione

doi:10.1055/s-0037-1613106

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 2002; 87(05): 923-924
DOI: 10.1055/s-0037-1613106

Letters to the Editor

Schattauer GmbH

Factor V Arg2074Cys: A Novel Missense Mutation in the C2 Domain of Factor V

Anna Bossone

¹Unita’ di Aterosclerosi e Trombosi, I.R.C.C.S. “Casa Sollievo della Sofferenza”, S. Giovanni Rotondo, Italy

,

Francesca D’Angelo

¹Unita’ di Aterosclerosi e Trombosi, I.R.C.C.S. “Casa Sollievo della Sofferenza”, S. Giovanni Rotondo, Italy

,

Rosa Santacroce

¹Unita’ di Aterosclerosi e Trombosi, I.R.C.C.S. “Casa Sollievo della Sofferenza”, S. Giovanni Rotondo, Italy

,

Domenico De Lucia

²Istituto di Patologia Generale e Oncologia, Seconda Università di Napoli, Italy

,

Maurizio Margaglione

³Genetica Medica, Università di Foggia, Italy

References
1 Van Wijk R, Nieuwenhuis K, van den Berg M, Huizinga EG, van der Meijden BB, Kraaijenhagen RJ, van Solinge WW. Five novel mutations in the gene for human blood coagulation factor V associated with type I factor V deficiency. Blood 2001; 98: 358-67.
2 Margaglione M, Santacroce R, Colaizzo D, Seripa D, Vecchione G, Lupone MR, De Lucia D, Fortina P, Grandone E, Perricone C, Di Minno G. A G-to-A mutation in ivs-3 of the human gamma fibrinogen gene causing afibrinogenemia due to abnormal rna splicing. Blood 2000; 96: 2501-5.
3 Ortel TL, Devore-Carter D, Quin-Allen MA, Kane WH. Deletion analysis of recombinant human factor V Evidence for a phosphatydilserine binding site in the second C-type domain. J Biol Chem 1992; 267: 4189-98.
4 Kim SW, Quin-Allen MA, Camp JT, Macedo-Ribeiro S, Fuentes-Prior P, Bode W, Kane WH. Identification of functionally important amino acid residues within the C2-domain of human factor V using alanine-scanning mutagenesis. Biochemistry 2000; 39: 1951-8.
5 Macedo-Ribeiro S, Bode W, Huber R, Quin-Allen MA, Kim SW, Ortel TL, Bourenkov GP, Bartunik HD, Stubbs MT, Kane WH, Fuentes-Prior P. Crystal structures of the membrane-binding C2 domain of human coagulation factor V. Nature 1999; 402: 434-9.
6 Kemball-Cook G, Tuddenham EG. The Factor VIII Mutation Database on the World Wide Web: the haemophilia A mutation, search, test and resource site HAMSTeRS update (version 3.0). Nucleic Acid Res 1997; 25: 128-32.
7 Schrijver I, Houissa-Kastally R, Jones CD, Zehnder JL. Identification of a novel factor V C2 domain mutation (R2074H) in two separate families with factor V deficiency and bleeding [abstract]. Blood 2000; 96: 533a.
8 Xue J, Kafalatis M, Mann KG. Determination of the disulfide bridges in factor Valight chain. Biochemistry 1993; 32: 5917-23.
9 Koopman J, Haverkate F, Grimbergen J, Egbring R, Lord ST. Fibrinogen Marburg: a homozygous case of dysfibrinogenemia, lacking amino acids Acx 461-610 (Lys 461 AAA-> stop TAA). Blood 1992; 80: 1972-9.
10 Furlan M, Steinmann C, Jungo M. et al. A frameshift mutation in exon V of the Acx-chain gene leading to truncated Acx-chains in the homozygous dysfibrinogen Milano III. J Biol Chem 1994; 269: 33129-34.
11 Collen A, Maas A, Kooistra T. et al. Aberrant fibrin formation and crosslinking of fibrinogen Nieuwegein, a variant with a shortened Acx-chain, alters endothelial capillary tube formation. Blood 2001; 97: 973-80.